MRSA/VRE infections driven by antibacterial use?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 550, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

There is a difference between the antibacterial susceptibility of community-associated and health care-associated MRSA

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Antibacterial Use in Pregnancy

By Weller T.M.A.  

Drug Safety, Vol. 22, Iss. 5, 2000-05 ,pp. : 335-338

Adis International

Access to resources Recommend Favorite

Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE)

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 4, 2007-10 ,pp. : 243-247

Bentham Science Publishers

Access to resources Recommend Favorite

New 3-Aminosteroid Derivatives as a New Family of Topical Antibacterial Agents Active against Methicillin-Resistant Staphylococcus aureus (MRSA)

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 3, 2008-04 ,pp. : 169-172

Bentham Science Publishers

Access to resources Recommend Favorite